Back
Voya Global Advantage and Premium Opportunity Fund Vs. Novartis AG Industry Stock Comparison
Buy
63
IGA
Voya Global Advantage and Premium Opportunity Fund
Last Price:
$9.57
Seasonality Move:
0.94%
Buy
62
NVSEF
Novartis AG
Last Price:
$109.00
Seasonality Move:
5.79%
Buy
63
Voya Global Advantage and Premium Opportunity Fund (IGA)
is a Buy
Is Voya Global Advantage and Premium Opportunity Fund a Buy, Sell or Hold?
-
The current Voya Global Advantage and Premium Opportunity Fund [IGA] share price is $9.59. The Score for IGA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
-
IGA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $109.00. The Score for NVSEF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
IGA Stock Price Chart
What is Voya Global Advantage and Premium Opportunity Fund's stock price today?
-
The Voya Global Advantage and Premium Opportunity Fund share price today is $9.59Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and IGA is experiencing selling pressure, which indicates risk of future bearish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $109.00The current trend is moderately bearish and NVSEF is experiencing buying pressure, which is a positive indicator for future bullish movement.
IGA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.04 | Buy |
Relative Strength Index (14 RSI): | 49.66 | Sell |
Chaikin Money Flow: | -9630 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (9.48 - 9.72) | Sell |
Bollinger Bands (100): | (9.33 - 9.63) | Buy |
NVSEF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.7 | Buy |
Relative Strength Index (14 RSI): | 49.51 | Sell |
Chaikin Money Flow: | 5487 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (104.67 - 112.23) | Buy |
Bollinger Bands (100): | (98.63 - 109.37) | Buy |
IGA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 9.66 | Sell |
20-day SMA: | 9.65 | Sell |
50-day SMA: | 9.48 | Buy |
200-day SMA: | 9.31 | Buy |
8-day EMA: | 9.63 | Sell |
20-day EMA: | 9.61 | Sell |
50-day EMA: | 9.54 | Buy |
200-day EMA: | 9.3 | Buy |
NVSEF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.29 | Sell |
20-day SMA: | 109.25 | Sell |
50-day SMA: | 103.73 | Buy |
200-day SMA: | 106.3 | Buy |
8-day EMA: | 112.15 | Sell |
20-day EMA: | 109.66 | Sell |
50-day EMA: | 106.19 | Buy |
200-day EMA: | 104.21 | Buy |
Voya Global Advantage and Premium Opportunity Fund Earnings Growth & IGA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Voya Global Advantage and Premium Opportunity Fund Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novartis AG Technical Analysis
Feb 26 | Feb 27 | Feb 28 | Mar 3 | Mar 4 | Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | |
---|---|---|---|---|---|---|---|---|---|---|
Feb | Mar | |||||||||
26 | 27 | 28 | 03 | 04 | 05 | 06 | 07 | 11 | 12 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |